News and Trends 13 Dec 2017
Biotech and Pharma Giants Make a Good Start to Phase II Trial for Skin Cancer
…mechanisms used by tumors to protect themselves from the immune system. In particular, PD-1 tells T cells not to attack cells that express its ligand, PD-L1. Checkpoint inhibitors that block…
